C. difficile Publications

C. difficile
  • ASM Recommendations for CDI
  • Burnham, Carey-Ann D, et al. “Clostridium difficile —Diagnostic and Clinical Challenges.” Clinical Chemistry, vol. 62, no. 2, Jan. 2016, pp. 310–314.,doi:10.1373/clinchem.2015.243717.
  • Caulfield, Adam J., et al. “Evaluation of 4 Molecular Assays as Part of a 2-Step Algorithm for the Detection of Clostridium difficile in Stool Specimens.” Diagnostic Microbiology and Infectious Disease, vol. 91, no. 1, 2018, pp. 1–5., doi:10.1016/j.diagmicrobio.2017.12.018.
  • CDC: Testing for C. difficile and Standardized Infection Ratios, National Healthcare Safety Network, 2019
  • Dubberke ER et al. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.  J Clinical Microbiology. 49(8):2887-93.
  • European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Crobach M.J.T., Planche T., Eckert C., Barbut F., Terveer E.M., Dekkers O.M., Wilcox M.H., Kuijper E.J. (2016) Clinical Microbiology and Infection,  22 , pp. S63-S81.
  • Gilligan PH. 2015. Optimizing the Laboratory Diagnosis of Clostridium difficile Infection .  Clin Lab Med. 35: 299–312.
  • Guh, Alice Y, et al. “Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.” Clinical Infectious Diseases, vol. 69, no. 10, 2019, pp. 1667–1674., doi:10.1093/cid/ciz009.
  • Johnson, Stuart. “The Rise and Fall and Rise Again of Toxin Testing for the Diagnosis of Clostridioides difficile Infection.” Clinical Infectious Diseases, vol. 69,no. 10, July 2019, pp. 1675–1677., doi:10.1093/cid/ciz012.
C. difficile and Intestinal Inflammation
C. DIFF QUIK CHEK COMPLETE®
C. DIFF QUIK CHEK®
TOX A/B QUIK CHEK®
C. DIFF CHEK  – 60
C. DIFFICILE TOX A/B II